Micro Therapeutics Inc.: The San Clemente developer...

Micro Therapeutics Inc.: The San Clemente developer of devices for the diagnosis and treatment of vascular diseases incurred a net loss for the first quarter of $1.8 million, or 33 cents a share, compared with a net loss of $1.2 million, or 37 cents a share, for the first quarter last year. Sales more than doubled to $510,039 from $232,913. The company completed its initial public offering on Feb. 18.